Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIBW 2948 BS in COPD with chronic bronchitis symptoms
2006-001975-40Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) comparing BIBW 2948 BS with Placebo (2 arms). Primary endpoint: Volume of mucin per surface area of basal lamina. Started Nov 2006; status: completed.
02
Drugs
BIBW 2948 BS
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on 2006-001975-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001975-40.